Work

Bowel Function and Global Quality of Life by Rectal Status After Neoadjuvant Treatment for Rectal Cancer: A Retrospective Cohort Study

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background: Organ preservation is expected to spare bowel function, but whether that gain is reflected in how patients rate their own quality of life is unclear. Methods: A retrospective comparative cohort study was conducted at a single tertiary center in 2021–2024. Of 52 patients with locally advanced rectal cancer receiving neoadjuvant treatment, 31 entered the watch-and-wait arm and 21 formed a comparator arm. Bowel function (LARS, Wexner, Vaizey) and quality of life (EORTC QLQ-C30, QLQ-CR29) were compared between TME-free (n = 13) and TME respondents (n = 20). Bowel function was the primary outcome family; the rest are exploratory and uncorrected for multiplicity. Results: Bowel function differed widely: median LARS 16.0 vs. 35.5, Wexner 2.0 vs. 11.5, Vaizey 2.0 vs. 15.0 (all p < 0.001), with major LARS in 15.4% vs. 90.0% (p < 0.001). No difference in global quality of life was detected (58.3 vs. 54.2; p = 0.615), or in physical or role functioning. Body image and six colorectal symptom scales favored the TME-free group, whereas blood or mucus, abdominal pain, buttock pain, and bloating showed none. Groups reflect rectal status at assessment, not randomized strategy. Eleven of 17 comparator patients had a coloanal anastomosis, nine of them at the anal verge itself, widening the functional contrast. Freedom from any rectal surgery was 74.2% (23 of 31) in the full arm and 68.4% (13 of 19) per protocol; median follow-up was 15 months. Conclusions: Bowel function was substantially better in TME-free respondents, while this small cross-sectional study did not detect a global quality-of-life difference. Its magnitude and generalizability await larger cohorts.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,137
OpenAlex ID: W7236707768
FWCI:
Cites: 46
Cited by:
Related to: 10